Cargando…

Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience

BACKGROUND: Immunofluorescence testing is an important tool for diagnosing blistering diseases. OBJECTIVE: To characterize the immunofluorescence findings in patients diagnosed with autoimmune blistering skin diseases. METHODS: We retrospectively analyzed immunofluorescence results encompassing a 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbache, Samia Trigo, Nogueira, Tarsila Gasparotto, Delgado, Lívia, Miyamoto, Denise, Aoki, Valéria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230656/
https://www.ncbi.nlm.nih.gov/pubmed/25387492
http://dx.doi.org/10.1590/abd1806-4841.20143221
_version_ 1782344310073589760
author Arbache, Samia Trigo
Nogueira, Tarsila Gasparotto
Delgado, Lívia
Miyamoto, Denise
Aoki, Valéria
author_facet Arbache, Samia Trigo
Nogueira, Tarsila Gasparotto
Delgado, Lívia
Miyamoto, Denise
Aoki, Valéria
author_sort Arbache, Samia Trigo
collection PubMed
description BACKGROUND: Immunofluorescence testing is an important tool for diagnosing blistering diseases. OBJECTIVE: To characterize the immunofluorescence findings in patients diagnosed with autoimmune blistering skin diseases. METHODS: We retrospectively analyzed immunofluorescence results encompassing a 10-year period. RESULTS: 421 patients were included and divided into 2 groups: group 1- intraepidermal blistering diseases (n=277) and 2- subepidermal blistering diseases (n=144). For group 1, positive DIF findings demonstrated: predominance of IgG intercellular staining (ICS) and C3 for pemphigus foliaceus-PF (94% and 73% respectively), pemphigus vulgaris-PV (91.5%-79.5%) and paraneoplastic pemphigus-PNP (66%-33%); ICS IgA in 100% of IgA pemphigus cases, and IgG deposits in the basement membrane zone (BMZ) along with ICS in one Hailey-Hailey patient. The IIF findings revealed mean titers of 1:2.560 for PV and 1:1.280 for PF. For paraneoplastic pemphigus, IIF was positive in 2 out of 3 cases with rat bladder substrate. In group 2, positive DIF findings included multiple deposits at basement membrane zone for epidermolysis bullosa acquisita-EBA (C3-89%,IgG-79%,IgA-47%,IgM-21%) mucous membrane pemphigoid-MMP (C3,IgG,IgA,IgM-80%) and bullous pemphigoid-BP (C3-91%,IgG-39%,IgA-11%,IgM-6%), and IgA at basement membrane zone for IgA linear disease (99%) and dermatitis herpetiformis-DH (dermal papillae in 84.6%). For lichen planus pemphigoides, there was C3 (100%) and IgG (50%) deposition at basement membrane zone. indirect immunofluorescence positive findings revealed basement membrane zone IgG deposits in 46% of BP patients, 50% for EBA, 15% for IgA linear dermatosis and 50% for LPP. Indirect immunofluorescence positive results were higher for BP and EBA with Salt-Split skin substrate. CONCLUSION: Our results confirmed the importance of immunofluorescence assays in diagnosing autoimmune blistering diseases, and higher sensitivity for indirect immunofluorescence when Salt-split skin technique is performed.
format Online
Article
Text
id pubmed-4230656
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-42306562014-11-14 Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience Arbache, Samia Trigo Nogueira, Tarsila Gasparotto Delgado, Lívia Miyamoto, Denise Aoki, Valéria An Bras Dermatol Investigation BACKGROUND: Immunofluorescence testing is an important tool for diagnosing blistering diseases. OBJECTIVE: To characterize the immunofluorescence findings in patients diagnosed with autoimmune blistering skin diseases. METHODS: We retrospectively analyzed immunofluorescence results encompassing a 10-year period. RESULTS: 421 patients were included and divided into 2 groups: group 1- intraepidermal blistering diseases (n=277) and 2- subepidermal blistering diseases (n=144). For group 1, positive DIF findings demonstrated: predominance of IgG intercellular staining (ICS) and C3 for pemphigus foliaceus-PF (94% and 73% respectively), pemphigus vulgaris-PV (91.5%-79.5%) and paraneoplastic pemphigus-PNP (66%-33%); ICS IgA in 100% of IgA pemphigus cases, and IgG deposits in the basement membrane zone (BMZ) along with ICS in one Hailey-Hailey patient. The IIF findings revealed mean titers of 1:2.560 for PV and 1:1.280 for PF. For paraneoplastic pemphigus, IIF was positive in 2 out of 3 cases with rat bladder substrate. In group 2, positive DIF findings included multiple deposits at basement membrane zone for epidermolysis bullosa acquisita-EBA (C3-89%,IgG-79%,IgA-47%,IgM-21%) mucous membrane pemphigoid-MMP (C3,IgG,IgA,IgM-80%) and bullous pemphigoid-BP (C3-91%,IgG-39%,IgA-11%,IgM-6%), and IgA at basement membrane zone for IgA linear disease (99%) and dermatitis herpetiformis-DH (dermal papillae in 84.6%). For lichen planus pemphigoides, there was C3 (100%) and IgG (50%) deposition at basement membrane zone. indirect immunofluorescence positive findings revealed basement membrane zone IgG deposits in 46% of BP patients, 50% for EBA, 15% for IgA linear dermatosis and 50% for LPP. Indirect immunofluorescence positive results were higher for BP and EBA with Salt-Split skin substrate. CONCLUSION: Our results confirmed the importance of immunofluorescence assays in diagnosing autoimmune blistering diseases, and higher sensitivity for indirect immunofluorescence when Salt-split skin technique is performed. Sociedade Brasileira de Dermatologia 2014 /pmc/articles/PMC4230656/ /pubmed/25387492 http://dx.doi.org/10.1590/abd1806-4841.20143221 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Investigation
Arbache, Samia Trigo
Nogueira, Tarsila Gasparotto
Delgado, Lívia
Miyamoto, Denise
Aoki, Valéria
Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title_full Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title_fullStr Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title_full_unstemmed Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title_short Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
title_sort immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
topic Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230656/
https://www.ncbi.nlm.nih.gov/pubmed/25387492
http://dx.doi.org/10.1590/abd1806-4841.20143221
work_keys_str_mv AT arbachesamiatrigo immunofluorescencetestinginthediagnosisofautoimmuneblisteringdiseasesoverviewof10yearexperience
AT nogueiratarsilagasparotto immunofluorescencetestinginthediagnosisofautoimmuneblisteringdiseasesoverviewof10yearexperience
AT delgadolivia immunofluorescencetestinginthediagnosisofautoimmuneblisteringdiseasesoverviewof10yearexperience
AT miyamotodenise immunofluorescencetestinginthediagnosisofautoimmuneblisteringdiseasesoverviewof10yearexperience
AT aokivaleria immunofluorescencetestinginthediagnosisofautoimmuneblisteringdiseasesoverviewof10yearexperience